SCHEMBL18907414

SCHEMBL18907414

c1ccc2cc3c(cc2c1)c(-c1c2ccccc2c(-c2ccncc2)c2ccccc12)nc1ccc2ccccc2c13

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.50
KDM4E B2RXH2 4/20 0.50
ALDH1A1 P00352 3/20 0.50
HPGD P15428 3/20 0.50
SMN1; SMN2 Q16637 2/20 0.43
MAPK10 P53779 3/20 0.40
MAPK9 P45984 2/20 0.40
MAPK8 P45983 1/20 0.40
ESR1 P03372 4/20 0.40
ESR2 Q92731 3/20 0.40
LMNA P02545 3/20 0.38
HTT P42858 2/20 0.38
POLB P06746 2/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
HSP90AA1 P07900 1/20 0.38
GAA P10253 1/20 0.38
PKM P14618 1/20 0.38
GRK6 P43250 1/20 0.38
NPY1R P25929 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18907332 0.86 MAPT (0.49) MAPTKDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL18907421 0.83 ESR1 (0.46) MAPTKDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL18907348 0.80 MAPK10 (0.41) MAPTKDM4EALDH1A1HPGDMAPK10
SCHEMBL18907289 0.78 MAPT (0.40) MAPTKDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL17034919 0.77 KDM4E (0.46) MAPTKDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL24662789 0.73 MAPK9 (0.56) MAPTKDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL18907413 0.73 KDM4E (0.39) MAPTKDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL18907412 0.72 MAPT (0.40) MAPTKDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL17034920 0.72 KDM4E (0.46) MAPTKDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL18748108 0.71 LMNA (0.38) MAPTKDM4EALDH1A1HPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170155057-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170155057-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, OCIAD1, CCNT1 MAPT 2043/4885KDM4E 2914/4885ALDH1A1 195/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.